Menu

Shingles May Be Related to Elevated Risk of Multiple Sclerosis

Author: Infectious Diseases Society of America
Published: 2011/06/12 - Updated: 2015/01/14

Contents: Synopsis - Introduction - Main - Related Publications

Synopsis: There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.

Introduction

There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.

Main Content

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack.

The findings, which support a long-held view on how MS may develop, are published in The Journal of Infectious Diseases and now available online.

MS is an autoimmune disease that affects the brain and spinal cord, leading to inflammation and nerve damage as the body's immune cells attack the nervous system. Possible causes that may trigger the inflammation include environmental, genetic, and viral factors. One virus that has been associated with MS is varicella zoster virus, the cause of herpes zoster.

In a study conducted by Herng-Ching Lin, PhD, and colleagues at Taipei Medical University in Taiwan, 315,550 adults with herpes zoster and a control group of 946,650 subjects were tracked and then evaluated for MS occurrence during a one-year follow-up period. The control group was selected randomly from a pool of subjects who had not been diagnosed with herpes zoster or other viral diseases.

After adjusting for monthly income and geographic region, the authors found that the group with herpes zoster had a 3.96 times higher risk of developing MS than the control group. The authors noted that this risk, although increased, was still low, as is the frequency of MS in general. The study also noted an interval of approximately 100 days between a herpes zoster event and occurrence of MS.

Although the study was limited almost entirely to Han Chinese adults, the large scope of this nationwide case-controlled study, 1.26 million sampled patients, provides strong epidemiological evidence for a possible role for herpes zoster in the development of MS. The authors also point out that MS has a lower prevalence in Asian compared to Western populations and, thus, it may be difficult to project their findings to other populations.

In an accompanying editorial, Teresa Corona, MD, and Jose Flores, MD, of the National Institute of Neurology and Neurosurgery in Mexico noted that "The evidence provided in this study...allows us to better understand the role of these viral factors as an MS risk among certain genetically susceptible individuals," and that the study should be corroborated in other parts of the world to help clarify the role of this and other viruses in MS.

Facts:

Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms.

New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment

Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment. Published: 2020/01/07.

Stigma Increases Risk of Depression for People with Multiple Sclerosis

Those with MS who feel stigmatized are more likely to have depression, having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma.. Published: 2018/03/01.

$7M MS Progression Cohort to Research Multiple Sclerosis in Canada

Research proposals will invite researchers to establish a Canadian cohort of people living with MS to study progression in the disease. Published: 2017/03/31.

How Can We Predict Whose Multiple Sclerosis Will Worsen?

Multiple Sclerosis study brings us closer to understanding which older adults with MS may be at higher risk of getting worse. Published: 2017/03/20.

Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis

Phase III CLARITY study data revealed significant reduction in brain atrophy in patients on short course of investigational Cladribine Tablets over two years. Published: 2017/02/13.

Multiple Sclerosis Onset Age Linked to Geographic Latitude

Study finds the age at which symptoms of multiple sclerosis (MS) first start is strongly linked to latitude. Published: 2016/11/07.

View the Full List of Related Publications

What People Are Saying

Start, or join, thought-provoking conversations with other Disabled World readers on this topic.

Share and Comment

Permalink:

<a href="https://www.disabled-world.com/health/autoimmunediseases/ms/elevated-risk-ms.php">Shingles May Be Related to Elevated Risk of Multiple Sclerosis</a>: There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.

While we strive to provide accurate, up-to-date information, our content is for general informational purposes only. Please consult qualified professionals for advice specific to your situation.